1	Retinoic	retinoic	_	_	_	_	_	_	_
2	acid	acid	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	CD40	CD40	_	_	_	_	_	_	_
5	+	+	_	_	_	_	_	_	_
6	interleukin-4-mediated	interleukin-4-mediated	_	_	_	_	_	_	_
7	IgE	ige	_	_	_	_	_	_	_
8	production	production	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	vitro	vitro	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	elucidate	elucidate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	role	role	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	retinoic	retinoic	_	_	_	_	_	_	_
7	acid	acid	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	RA	RA	_	_	_	_	_	_	_
10	)	)	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	anti-CD40	anti-cd40	_	_	_	_	_	_	_
13	+	+	_	_	_	_	_	_	_
14	interleukin-4	interleukin-4	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	IL-4)-mediated	il-4)-mediated	_	_	_	_	_	_	_
17	B-cell	B-cell	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	effect	effect	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	10(-12)	10(-12)	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	10(-6)	10(-6)	_	_	_	_	_	_	_
26	mol/L	mol/l	_	_	_	_	_	_	_
27	RA	RA	_	_	_	_	_	_	_
28	was	be	_	_	_	_	_	_	_
29	studied	study	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	anti-CD40	anti-cd40	_	_	_	_	_	_	_
32	(	(	_	_	_	_	_	_	_
33	1	1	_	_	_	_	_	_	_
34	microgram/mL	microgram/ml	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	+	+	_	_	_	_	_	_	_
37	IL-4	il-4	_	_	_	_	_	_	_
38	(	(	_	_	_	_	_	_	_
39	5	5	_	_	_	_	_	_	_
40	ng/mL)-mediated	ng/ml)-mediated	_	_	_	_	_	_	_
41	proliferation	proliferation	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	Ig	ig	_	_	_	_	_	_	_
44	synthesis	synthesis	_	_	_	_	_	_	_
45	by	by	_	_	_	_	_	_	_
46	human	human	_	_	_	_	_	_	_
47	peripheral	peripheral	_	_	_	_	_	_	_
48	blood	blood	_	_	_	_	_	_	_
49	mononuclear	mononuclear	_	_	_	_	_	_	_
50	cells	cell	_	_	_	_	_	_	_
51	(	(	_	_	_	_	_	_	_
52	PBMC	PBMC	_	_	_	_	_	_	_
53	)	)	_	_	_	_	_	_	_
54	and	and	_	_	_	_	_	_	_
55	B	B	_	_	_	_	_	_	_
56	cells	cell	_	_	_	_	_	_	_
57	in	in	_	_	_	_	_	_	_
58	healthy	healthy	_	_	_	_	_	_	_
59	donors	donor	_	_	_	_	_	_	_
60	.	.	_	_	_	_	_	_	_

1	Anti-CD40	Anti-CD40	_	_	_	_	_	_	_
2	+	+	_	_	_	_	_	_	_
3	IL-4-mediated	il-4-mediated	_	_	_	_	_	_	_
4	proliferation	proliferation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	PBMC	PBMC	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	inhibited	inhibit	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	RA	RA	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	dose-dependent	dose-dependent	_	_	_	_	_	_	_
17	manner	manner	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	maximal	maximal	_	_	_	_	_	_	_
21	inhibition	inhibition	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	62	62	_	_	_	_	_	_	_
24	%	%	_	_	_	_	_	_	_
25	+/-	+/-	_	_	_	_	_	_	_
26	5	5	_	_	_	_	_	_	_
27	%	%	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	PBMC	PBMC	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	55	55	_	_	_	_	_	_	_
32	%	%	_	_	_	_	_	_	_
33	+/-	+/-	_	_	_	_	_	_	_
34	4.4	4.4	_	_	_	_	_	_	_
35	%	%	_	_	_	_	_	_	_
36	in	in	_	_	_	_	_	_	_
37	B	B	_	_	_	_	_	_	_
38	cells	cell	_	_	_	_	_	_	_
39	by	by	_	_	_	_	_	_	_
40	all-trans	all-trans	_	_	_	_	_	_	_
41	RA	RA	_	_	_	_	_	_	_
42	,	,	_	_	_	_	_	_	_
43	and	and	_	_	_	_	_	_	_
44	58	58	_	_	_	_	_	_	_
45	%	%	_	_	_	_	_	_	_
46	+/-	+/-	_	_	_	_	_	_	_
47	6.7	6.7	_	_	_	_	_	_	_
48	%	%	_	_	_	_	_	_	_
49	and	and	_	_	_	_	_	_	_
50	51	51	_	_	_	_	_	_	_
51	%	%	_	_	_	_	_	_	_
52	+/-	+/-	_	_	_	_	_	_	_
53	4.7	4.7	_	_	_	_	_	_	_
54	%	%	_	_	_	_	_	_	_
55	,	,	_	_	_	_	_	_	_
56	respectively	respectively	_	_	_	_	_	_	_
57	by	by	_	_	_	_	_	_	_
58	13-cis	13-cis	_	_	_	_	_	_	_
59	RA	RA	_	_	_	_	_	_	_
60	.	.	_	_	_	_	_	_	_

1	IgE	IgE	_	_	_	_	_	_	_
2	synthesis	synthesis	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	even	even	_	_	_	_	_	_	_
5	more	more	_	_	_	_	_	_	_
6	markedly	markedly	_	_	_	_	_	_	_
7	inhibited	inhibit	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	RA	RA	_	_	_	_	_	_	_
10	starting	start	_	_	_	_	_	_	_
11	at	at	_	_	_	_	_	_	_
12	concentrations	concentration	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	>10(-14)	>10(-14)	_	_	_	_	_	_	_
15	mol/L	mol/l	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	>10(-10)	>10(-10)	_	_	_	_	_	_	_
21	mol/L	mol/l	_	_	_	_	_	_	_
22	for	for	_	_	_	_	_	_	_
23	PBMC	PBMC	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Maximal	maximal	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	IgE	ige	_	_	_	_	_	_	_
5	production	production	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	at	at	_	_	_	_	_	_	_
11	10(-8)	10(-8)	_	_	_	_	_	_	_
12	mol/L	mol/l	_	_	_	_	_	_	_
13	for	for	_	_	_	_	_	_	_
14	all-trans	all-trans	_	_	_	_	_	_	_
15	RA	RA	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	94	94	_	_	_	_	_	_	_
18	%	%	_	_	_	_	_	_	_
19	+/-	+/-	_	_	_	_	_	_	_
20	1.8	1.8	_	_	_	_	_	_	_
21	%	%	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	96	96	_	_	_	_	_	_	_
25	%	%	_	_	_	_	_	_	_
26	+/-	+/-	_	_	_	_	_	_	_
27	3.2	3.2	_	_	_	_	_	_	_
28	%	%	_	_	_	_	_	_	_
29	for	for	_	_	_	_	_	_	_
30	13-cis	13-cis	_	_	_	_	_	_	_
31	RA	RA	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Low	low	_	_	_	_	_	_	_
2	concentrations	concentration	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	RA	RA	_	_	_	_	_	_	_
5	inhibiting	inhibit	_	_	_	_	_	_	_
6	IgE	ige	_	_	_	_	_	_	_
7	synthesis	synthesis	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	10(-10)	10(-10)	_	_	_	_	_	_	_
10	mol/L	mol/l	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	affected	affect	_	_	_	_	_	_	_
13	neither	neither	_	_	_	_	_	_	_
14	B-cell	b-cell	_	_	_	_	_	_	_
15	proliferation	proliferation	_	_	_	_	_	_	_
16	nor	nor	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	production	production	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	IgA	IgA	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	IgG	IgG	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	IgM	IgM	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Elucidation	elucidation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	mechanism	mechanism	_	_	_	_	_	_	_
5	involved	involve	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	this	this	_	_	_	_	_	_	_
8	inhibition	inhibition	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	IgE	IgE	_	_	_	_	_	_	_
11	production	production	_	_	_	_	_	_	_
12	shows	show	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	epsilon	epsilon	_	_	_	_	_	_	_
15	germline	germline	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	is	be	_	_	_	_	_	_	_
18	decreased	decrease	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	RA	RA	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	whereas	whereas	_	_	_	_	_	_	_
23	production	production	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	interferon-gamma	interferon-gamma	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	was	be	_	_	_	_	_	_	_
30	not	not	_	_	_	_	_	_	_
31	enhanced	enhance	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	presence	presence	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	RA	RA	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	differentiate	differentiate	_	_	_	_	_	_	_
3	whether	whether	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	RA	RA	_	_	_	_	_	_	_
6	effect	effect	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	mediated	mediate	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	RA	RA	_	_	_	_	_	_	_
11	receptors	receptor	_	_	_	_	_	_	_
12	alpha	alpha	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	beta	beta	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	gamma	gamma	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	retinoic	retinoic	_	_	_	_	_	_	_
24	acid	acid	_	_	_	_	_	_	_
25	receptors	receptor	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	RAR	RAR	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	was	be	_	_	_	_	_	_	_
30	examined	examine	_	_	_	_	_	_	_
31	by	by	_	_	_	_	_	_	_
32	reverse	reverse	_	_	_	_	_	_	_
33	transcriptase-polymerase	transcriptase-polymerase	_	_	_	_	_	_	_
34	chain	chain	_	_	_	_	_	_	_
35	reaction	reaction	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	RT-PCR	RT-PCR	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	unstimulated	unstimulated	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	peripheral	peripheral	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	express	express	_	_	_	_	_	_	_
11	mRNA	mrna	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	RA	RA	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	alpha	alpha	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	beta	beta	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	gamma	gamma	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	retinoids	retinoid	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	different	different	_	_	_	_	_	_	_
5	receptor	receptor	_	_	_	_	_	_	_
6	binding	binding	_	_	_	_	_	_	_
7	specificity	specificity	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	CD336	CD336	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	CD437	CD437	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	CD2019	CD2019	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	CD367	CD367	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	dose-dependent	dose-dependent	_	_	_	_	_	_	_
19	inhibition	inhibition	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	IgE	IgE	_	_	_	_	_	_	_
22	synthesis	synthesis	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	shown	show	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	all	all	_	_	_	_	_	_	_
27	four	four	_	_	_	_	_	_	_
28	derivates	derivate	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	but	but	_	_	_	_	_	_	_
31	was	be	_	_	_	_	_	_	_
32	most	most	_	_	_	_	_	_	_
33	marked	mark	_	_	_	_	_	_	_
34	by	by	_	_	_	_	_	_	_
35	an	an	_	_	_	_	_	_	_
36	RA	RA	_	_	_	_	_	_	_
37	binding	bind	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	alpha	alpha	_	_	_	_	_	_	_
40	receptor	receptor	_	_	_	_	_	_	_
41	with	with	_	_	_	_	_	_	_
42	high	high	_	_	_	_	_	_	_
43	specificity	specificity	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	Taken	take	_	_	_	_	_	_	_
2	together	together	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	study	study	_	_	_	_	_	_	_
6	shows	show	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	RA	RA	_	_	_	_	_	_	_
9	inhibits	inhibit	_	_	_	_	_	_	_
10	IgE	ige	_	_	_	_	_	_	_
11	production	production	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	anti-CD40	anti-cd40	_	_	_	_	_	_	_
14	+	+	_	_	_	_	_	_	_
15	IL-4-stimulated	il-4-stimulated	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	vitro	vitro	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Copyright	Copyright	_	_	_	_	_	_	_
2	1998	1998	_	_	_	_	_	_	_
3	by	by	_	_	_	_	_	_	_
4	The	The	_	_	_	_	_	_	_
5	American	American	_	_	_	_	_	_	_
6	Society	Society	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	Hematology	Hematology	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

